Fundz

First Wave Bio Pharma reported raising $300,000 in an initial SEC Form D filing, from an offering of $300,000

PRIVATEJul 26, 2022

Amount Raised

$300,000

$300,000 sold, per SEC Form D (first sale Jul 15, 2022)

Round Type

Seed

Boca RatonBiotechnologyTherapeuticsPharmaceuticalBiopharma

Quick answer

Entero Therapeutics raised $300,000 in a Seed round, dated July 15, 2022. Entero Therapeutics is based in Boca Raton, Florida, United States.

How much did Entero Therapeutics raise?
Entero Therapeutics raised $300,000 in a Seed round on July 15, 2022.
What does Entero Therapeutics do?
Entero Therapeutics, Inc. (Nasdaq: ENTO) is a clinical-stage biopharmaceutical company focused on gastrointestinal product pipeline for treating unmet metabolic and rare genetic diseases, including latiglutenase,..
Where is Entero Therapeutics based and how big is it?
Entero Therapeutics is based in Boca Raton, Florida, United States.

Source: Fundz verified event record.

Who else raised in Therapeutics and Pharmaceutical around the same time

Companies in the same sectors as Entero Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • LumaBridge raised an undisclosed amount (Private Equity) on August 23, 2022.
  • Structure Therapeutics raised an undisclosed amount (Funding Round) on August 1, 2022.
  • MIRA Pharmaceuticals raised $625K (Seed) on July 22, 2022.
  • Gossamer Bio raised $120M on July 15, 2022.
  • Gossamer Bio raised $120M (Post-IPO Equity) on July 13, 2022.
  • Avelos Therapeutics raised an undisclosed amount (Series A) on August 22, 2022.

Who to call at Entero Therapeutics, and when

A new round usually means Entero Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Entero Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Entero Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Entero Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Entero Therapeutics

Location

Boca Raton, Florida, United States

About

Entero Therapeutics, Inc. (Nasdaq: ENTO) is a clinical-stage biopharmaceutical company focused on gastrointestinal product pipeline for treating unmet metabolic and rare genetic diseases, including latiglutenase, adrulipase, and capeserod. The company also aims to create a Nasdaq-listed, clinical-stage biopharmaceutical company through the reverse merger with Journey Therapeutics, Inc.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Entero Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Entero Therapeutics's next move

See what Strategic adds

Entero Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.